Cargando…
Fibrinolytic therapy for parapneumonic empyema during pregnancy
Pneumonia and parapneumonic complicated effusion during pregnancy is uncommon but poses potentially serious risks to both mother and fetus. Enzymatic debridement of the pleural cavity with fibrinolytic agents is a noninvasive option that can facilitate drainage and prevent the need for surgery. Here...
Autores principales: | Ulutas, Hakki, Yekeler, Erdal, Ali Sak, Zafer Hasan, Doru, Ihsan, Kuzucu, Akin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920424/ https://www.ncbi.nlm.nih.gov/pubmed/26057709 http://dx.doi.org/10.1016/j.rmedc.2011.08.005 |
Ejemplares similares
-
VATS and Intrapleural Fibrinolytic Therapy for Parapneumonic Empyema
por: Ohara, Gen, et al.
Publicado: (2018) -
Efficacy of standardizing fibrinolytic therapy for parapneumonic effusion
por: James, Charles A., et al.
Publicado: (2022) -
Pediatric Parapneumonic Empyema, Spain
por: Obando, Ignacio, et al.
Publicado: (2008) -
Treatment of complicated parapneumonic pleural effusion and pleural parapneumonic empyema
por: Suárez, Pedro Rodríguez, et al.
Publicado: (2012) -
The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review
por: Nasralla, Awrad, et al.
Publicado: (2021)